Oppenheimer Reiterates Outperform on NuCana, Maintains $4 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Leland Gershell has reiterated an Outperform rating on NuCana (NASDAQ:NCNA) and maintained a $4 price target on the stock.
November 21, 2023 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Leland Gershell reaffirmed an Outperform rating on NuCana with a consistent price target of $4, indicating a positive outlook for the stock.
The reiteration of an Outperform rating by a reputable analyst like Leland Gershell suggests a strong vote of confidence in NuCana's prospects. The maintained price target of $4 implies a positive view on the stock's potential performance, which could influence investor sentiment and drive short-term price movement in a positive direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100